Vytrus Biotech (VYT.MC) Stock Price
Vytrus Biotech Price
Revenue has compounded at 37.8% per year over the past 7 years to 8.37 M EUR. Earnings per share have grown at 67.9% per year over the last 5 years. Vytrus Biotech's net margin stands at 34.6%, up from 16.0% several years earlier.
Vytrus Biotech stock price
Vytrus Biotech business model & stock analysis
Frequently asked questions about Vytrus Biotech
The expected revenue of Vytrus Biotech is 10.66 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Vytrus Biotech is 3.65 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Vytrus Biotech is currently 31.02. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Vytrus Biotech stock.
The price-to-sales ratio (P/S) of Vytrus Biotech is currently 10.61. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Vytrus Biotech stock.
The Eulerpool Quality Score for Vytrus Biotech is 5/10.
The ISIN of Vytrus Biotech is ES0105618005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Vytrus Biotech is A3DHK4. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Vytrus Biotech is VYT.MC. The ticker symbol is used to trade Vytrus Biotech shares on the stock exchange.
Vytrus Biotech stock
Vytrus Biotech Peer Group
Vytrus Biotech FIGI
All fundamentals and in-depth analysis of Vytrus Biotech
Our stock analysis for Vytrus Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vytrus Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.